Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
about
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma.Variation in protein levels obtained from human blood cells and biofluids for platelet, peripheral blood mononuclear cell, plasma, urine and saliva proteomicsAdult Acute Myeloid Leukemia Long-term Survivors.Does chemotherapy modify the immune surveillance of hematological malignancies?Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cellsDemographic and prognostic factors of 455 patients with acute leukemia admitted to two referral hospitals in tehran-iran during ten years (2001-2011).Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomideLocalization, expression change in PRRSV infection and association analysis of the porcine TAP1 geneA prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy.Myelosuppression and infectious complications in children with Down syndrome and acute lymphoblastic leukemia.Absolute lymphocyte counts refine minimal residual disease-based risk stratification in childhood acute lymphoblastic leukemia.Low platelet counts after induction therapy for childhood acute lymphoblastic leukemia are strongly associated with poor early response to treatment as measured by minimal residual disease and are prognostic for treatment outcomeRisk factors and characteristics of blood stream infections in patients with newly diagnosed multiple myeloma.Gene polymorphisms of ABC transporters are associated with clinical outcomes in children with acute lymphoblastic leukemia.Immunologic consequences of chemotherapy for acute myeloid leukemia.Patterns of Radiation-Associated Lymphopenia in Children with CancerHost immunity and survival.Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood acute lymphoblastic leukemia.Immunotherapy prospects for acute myeloid leukaemia.Molecular diagnosis and risk-adjusted therapy in pediatric hematologic malignancies: a primer for pediatricians.Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use.Confocal backscattering-based detection of leukemic cells in flowing blood samples.Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia.Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.Early chemosensitivity of normal hematopoietic cells and malignant lymphoblasts predicts relapse in childhood acute lymphoblastic leukemia.Use of intrathecal chemoprophylaxis in children after SCT and the risk of central nervous system relapse.Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas.Absolute lymphocyte count at day 28 independently predicts event-free and overall survival in adults with newly diagnosed acute lymphoblastic leukemia.Absolute lymphocyte counts at end of induction correlate with distinct immune cell compartments in pediatric B cell precursor acute lymphoblastic leukemia.Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer.Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.The neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with peripheral T-cell lymphoma, unspecified.Redefining clinical risk classification in children with precursor B cell acute lymphoblastic leukemia using pre-treatment absolute lymphocyte count.Absolute Lymphocyte Count (ALC) after Induction Treatment Predicts Survival of Pediatric Patients with Acute Lymphoblastic Leukemia.The prognostic significance of lymphopenia in peripheral T-cell and natural killer/T-cell lymphomas: a study of 826 cases from the International Peripheral T-cell Lymphoma Project.Pretreatment serum level of 15-kDa granulysin might have a prognostic value in patients with diffuse large B cell lymphoma.Is Absolute Lymphocyte Count Just Another Prognostic Factor in Cancer?
P2860
Q26770391-AC53B09E-20A0-4148-956F-DA5F2D181AE7Q31116522-029252DE-9F7E-48AB-87F1-163DC9F891CCQ33437720-119D2E4A-4E60-497A-8DB2-31BAE5CCCCA1Q34202366-F0430D1E-407C-407E-BCF4-A242DDB1A167Q34223517-206CECFD-81D9-4463-A88A-BA20AE8E9606Q34542123-743B441E-9F8E-4AD9-B492-2431270A3D2FQ34959094-2E647AE2-4A6E-4E20-AEA2-D43CE428B3E3Q35167257-F8E36511-C531-41C7-9EB6-954191CD248CQ35578741-95EBC2E7-A82B-470C-AECE-8B0160B3D00DQ35617517-6C4A036A-E094-42F6-8272-AD4D89044F85Q35752854-107B4309-E13E-433B-94FD-A833064B4C8DQ35757411-D5C809A7-2679-44EC-8C00-564387E05F8CQ35791247-91F56BE0-987E-4FC4-AAF4-86C57FF698DDQ35794444-03EE5907-71F5-4D46-B880-1FB8104AF1A6Q36240971-189752BB-5118-4BB3-BE28-304668BC4A3BQ36286302-92233F33-D664-4E7B-9F17-734A4330012AQ36478891-C10B5DF1-A35F-4B09-8207-E3388818201BQ36663654-4BFFF8A3-7C1A-4D5C-B9A2-FEB0726DAB71Q37157427-13CDBC82-8F4C-4B61-A697-AF88BC74CACEQ37389632-6FF90EB4-B836-4C4F-AB5A-26BCAD381DA3Q37763280-E49BEA2D-255A-4756-9DA5-E1A8AB3AEE97Q37847072-359EC787-B4D3-4616-92CB-BAAC6ED5ECB9Q38183943-CC2A26A6-DF28-4FF8-AE70-0E547AE0022DQ39531088-C01E246C-CAF5-4F00-AC2D-E37EBB3D6CD3Q40445337-CBA2A472-EDBB-407C-9444-F5ED153AD5C0Q41257297-05B290E7-18BF-4C53-BC57-93EDFD58C771Q42262922-9D158A8D-D47B-4806-A2C2-F076889E8485Q45854748-BDCB12DF-92F3-4D8A-9C3A-09FB03A5DBACQ46660874-454B60FA-C74C-416F-86BA-43D776E06523Q47581845-471F6BBD-FFCD-48A8-B6C8-2A8D4D631486Q48156506-5AD98908-2E73-4930-97AD-50883DAE0371Q48215618-E7E32B43-C620-4B49-A147-3B6032603806Q48654812-F159BE30-560E-4969-B630-23B8264BCEDFQ49085795-2609472B-E8E1-48EB-88BD-500D7191ED64Q50438156-BE577E4B-4BC1-473F-9CA1-BD5523DB7C52Q50922836-68B37834-41F8-4DF9-9E03-15EE2C9D5DB3Q53132335-EA2E3F20-99BC-4069-94E8-3204DCAB8C35Q53250468-AD0948BB-4196-407D-9CA0-E0606719BF0EQ58650169-B0DC425E-24EB-4DC4-992C-E3C3F8B1DFBA
P2860
Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Absolute lymphocyte count is a ...... tification and future studies.
@en
type
label
Absolute lymphocyte count is a ...... tification and future studies.
@en
prefLabel
Absolute lymphocyte count is a ...... tification and future studies.
@en
P2093
P356
P1433
P1476
Absolute lymphocyte count is a ...... tification and future studies.
@en
P2093
Carrie Yuen
Guillermo De Angulo
Peter M Anderson
Shana L Palla
P304
P356
10.1002/CNCR.23168
P407
P577
2008-01-01T00:00:00Z